次世代避妊薬市場- 世界および地域別分析：世界および地域別分析：性別、オファリング別、エンドユーザー別、地域別 - 分析と予測（2024年～2033年）

当レポートでは、世界の次世代避妊薬市場について調査し、市場の概要とともに、性別、オファリング別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 市場：業界の展望

• 動向：現在および将来の影響評価
• サプライチェーンの概要
• R&Dレビュー
• 規制状況
• 市場力学の概要

第2章 次世代避妊薬市場（用途別）

• 用途のセグメンテーション
• 用途の概要
• 世界の次世代避妊薬市場、性別
• 世界の次世代避妊薬市場、エンドユーザー別

第3章 次世代避妊薬市場、製品タイプ別

• 製品セグメンテーション
• 製品概要
• 世界の次世代避妊薬市場、オファリング別

第4章 次世代避妊薬市場、地域別

• 地域別概要
• 促進要因と抑制要因
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第5章 市場-競合情勢と企業プロファイル

• 競合情勢
• 企業プロファイル
  • AbbVie
  • Bayer Corporation
  • Cooper Surgical, Inc.
  • Church & Dwight Co, Inc.
  • Merck & Co Inc.
  • Pfizer
  • Reckitt Benckiser Group Plc
  • Teva Pharmaceuticals Industries Ltd.
  • The Female Health Company/Veru Inc.
  • Afaxys, Inc
  • Aditxt
  • Dare Bioscience, Inc
  • TherapeuticsMD, Inc
  • その他の企業

第6章 調査手法

This report will be delivered in 7-10 working days.

The global next-generation contraceptives market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities, and forecasts that a decision-maker can take advantage of.

The market study encompasses a detailed examination of various next-generation contraceptives including technological advancements, and market dynamics. It explores the market based on segmentations such as by gender, and by offering and by distribution channel and highlights the competitive landscape, profiling key players and their strategies for market expansion. The report delves into regional segmentation, evaluating market performance across different geographical areas. Additionally, it discusses the impact of macroeconomic factors on market growth and explores potential investment opportunities for stakeholders.

With a focus on fostering a deep understanding of market dynamics, the report serves as a valuable resource for businesses, investors, and industry participants seeking strategic insights into the evolving global next-generation contraceptives market.

Market Segmentation

Segmentation 1: by Gender

• Male
• Female

Segmentation 2: by by End User

• Hospital Pharmacies
• Retail Pharmacies
• Online Channels
• Others

Segmentation 3: by Offering

• Drugs
• Devices

Segmentation 4: by Region

• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• Latin America

Key Questions Answered:

• What are the major market drivers, challenges, and opportunities in the global next-generation contraceptives market and their case studies?
• How will the next-generation contraceptives market evolve and what is its scope in the future?
• What is the market share of the leading segments and sub-segments of the global next-generation contraceptives market?
• How will each segment of the global next-generation contraceptives market grow during the forecast period?
• What are the key developmental strategies implemented by the key players to stand out in this market?

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Key Questions Answered

Analysis and Forecast Note

1 Markets: Industry Outlook

• 1.1 Trends: Current and Future Impact Assessment
• 1.2 Supply Chain Overview
  • 1.2.1 Value chain Analysis
  • 1.2.2 Market Map
• 1.3 R&D Review
  • 1.3.1 Patent Filing Trend by Country, by Company
• 1.4 Regulatory Landscape
• 1.5 Market Dynamics Overview
  • 1.5.1 Market Drivers
  • 1.5.2 Market Restraints
  • 1.5.3 Market Opportunities

2 Next-Generation Contraceptives Market by Application

• 2.1 Application Segmentation
• 2.2 Application Summary
• 2.3 Global Next-Generation Contraceptives Market, by Gender
  • 2.3.1 Male
  • 2.3.2 Female
• 2.4 Global Next-Generation Contraceptives Market, by End User
  • 2.4.1 Hospital Pharmacies
  • 2.4.2 Retail Pharmacies
  • 2.4.3 Online Channels
  • 2.4.4 Others

3 Next-Generation Contraceptives Market by Product Type

• 3.1 Product Segmentation
• 3.2 Product Summary
• 3.3 Global Next-Generation Contraceptives Market, by Offering
  • 3.3.1 Drugs
    • 3.3.1.1 Contraceptive Pills
    • 3.3.1.2 Injectables
    • 3.3.1.3 Patches
    • 3.3.1.4 Others
  • 3.3.2 Devices
    • 3.3.2.1 Condoms
    • 3.3.2.2 Vaginal Rings
    • 3.3.2.3 Intra-uterine Devices
    • 3.3.2.4 Others

4 Next-Generation Contraceptives Market by Region

• 4.1 Regional Summary
• 4.2 Drivers and Restraints as you go along...
• 4.3 North America
  • 4.3.1 Markets
    • 4.3.1.1 Key Market Participants in North America
    • 4.3.1.2 Business Drivers
    • 4.3.1.3 Business Challenges
  • 4.3.2 North America Next Generation Contraceptives Market, by End User
  • 4.3.3 North America by Country
    • 4.3.3.1 U.S.
    • 4.3.3.2 Canada
• 4.4 Europe
  • 4.4.1 Markets
    • 4.4.1.1 Key Market Participants in Europe
    • 4.4.1.2 Business Drivers
    • 4.4.1.3 Business Challenges
  • 4.4.2 Europe Next Generation Contraceptives Market, by End User
  • 4.4.3 Europe by Country
    • 4.4.3.1 U.K.
    • 4.4.3.2 Germany
    • 4.4.3.3 France
    • 4.4.3.4 Italy
    • 4.4.3.5 Spain
    • 4.4.3.6 Rest of Europe
• 4.5 Asia-Pacific
  • 4.5.1 Markets
    • 4.5.1.1 Key Market Participants in Asia-Pacific
    • 4.5.1.2 Business Drivers
    • 4.5.1.3 Business Challenges
  • 4.5.2 Asia-Pacific America Next Generation Contraceptives Market, by End User
  • 4.5.3 Asia-Pacific by Country
    • 4.5.3.1 China
    • 4.5.3.2 Japan
    • 4.5.3.3 India
    • 4.5.3.4 South Korea
    • 4.5.3.5 Rest of Asia-Pacific
• 4.6 Latin America
  • 4.6.1 Markets
    • 4.6.1.1 Key Market Participants in Latin America
    • 4.6.1.2 Business Drivers
    • 4.6.1.3 Business Challenges
  • 4.6.2 Latin America Next Generation Contraceptives Market, by End User
  • 4.6.3 Latin America by Country
    • 4.6.3.1 Brazil
    • 4.6.3.2 Mexico
    • 4.6.3.3 Rest of Latin America
• 4.7 Middle East and Africa
  • 4.7.1 Markets
    • 4.7.1.1 Key Market Participants in Middle East and Africa
    • 4.7.1.2 Business Drivers
    • 4.7.1.3 Business Challenges
  • 4.7.2 Middle East and Africa Next Generation Contraceptives Market, by End User

5 Markets - Competitive Landscape & Company Profiles

• 5.1 Competitive Landscape
• 5.2 Company Profiles
  • 5.2.1 AbbVie
    • 5.2.1.1 Company Overview
    • 5.2.1.2 Top Products / Product Portfolio
    • 5.2.1.3 Top Competitors
    • 5.2.1.4 Target Customers /End-Users
    • 5.2.1.5 Key Personnel
    • 5.2.1.6 Analyst View
  • 5.2.2 Bayer Corporation
    • 5.2.2.1 Company Overview
    • 5.2.2.2 Top Products / Product Portfolio
    • 5.2.2.3 Top Competitors
    • 5.2.2.4 Target Customers /End-Users
    • 5.2.2.5 Key Personnel
    • 5.2.2.6 Analyst View
  • 5.2.3 Cooper Surgical, Inc.
    • 5.2.3.1 Company Overview
    • 5.2.3.2 Top Products / Product Portfolio
    • 5.2.3.3 Top Competitors
    • 5.2.3.4 Target Customers /End-Users
    • 5.2.3.5 Key Personnel
    • 5.2.3.6 Analyst View
  • 5.2.4 Church & Dwight Co, Inc.
    • 5.2.4.1 Company Overview
    • 5.2.4.2 Top Products / Product Portfolio
    • 5.2.4.3 Top Competitors
    • 5.2.4.4 Target Customers /End-Users
    • 5.2.4.5 Key Personnel
    • 5.2.4.6 Analyst View
  • 5.2.5 Merck & Co Inc.
    • 5.2.5.1 Company Overview
    • 5.2.5.2 Top Products / Product Portfolio
    • 5.2.5.3 Top Competitors
    • 5.2.5.4 Target Customers /End-Users
    • 5.2.5.5 Key Personnel
    • 5.2.5.6 Analyst View
  • 5.2.6 Pfizer
    • 5.2.6.1 Company Overview
    • 5.2.6.2 Top Products / Product Portfolio
    • 5.2.6.3 Top Competitors
    • 5.2.6.4 Target Customers /End-Users
    • 5.2.6.5 Key Personnel
    • 5.2.6.6 Analyst View
  • 5.2.7 Reckitt Benckiser Group Plc
    • 5.2.7.1 Company Overview
    • 5.2.7.2 Top Products / Product Portfolio
    • 5.2.7.3 Top Competitors
    • 5.2.7.4 Target Customers /End-Users
    • 5.2.7.5 Key Personnel
    • 5.2.7.6 Analyst View
  • 5.2.8 Teva Pharmaceuticals Industries Ltd.
    • 5.2.8.1 Company Overview
    • 5.2.8.2 Top Products / Product Portfolio
    • 5.2.8.3 Top Competitors
    • 5.2.8.4 Target Customers /End-Users
    • 5.2.8.5 Key Personnel
    • 5.2.8.6 Analyst View
  • 5.2.9 The Female Health Company/Veru Inc.
    • 5.2.9.1 Company Overview
    • 5.2.9.2 Top Products / Product Portfolio
    • 5.2.9.3 Top Competitors
    • 5.2.9.4 Target Customers /End-Users
    • 5.2.9.5 Key Personnel
    • 5.2.9.6 Analyst View
  • 5.2.10 Afaxys, Inc
    • 5.2.10.1 Company Overview
    • 5.2.10.2 Top Products / Product Portfolio
    • 5.2.10.3 Top Competitors
    • 5.2.10.4 Target Customers /End-Users
    • 5.2.10.5 Key Personnel
    • 5.2.10.6 Analyst View
  • 5.2.11 Aditxt
    • 5.2.11.1 Company Overview
    • 5.2.11.2 Top Products / Product Portfolio
    • 5.2.11.3 Top Competitors
    • 5.2.11.4 Target Customers /End-Users
    • 5.2.11.5 Key Personnel
    • 5.2.11.6 Analyst View
  • 5.2.12 Dare Bioscience, Inc
    • 5.2.12.1 Company Overview
    • 5.2.12.2 Top Products / Product Portfolio
    • 5.2.12.3 Top Competitors
    • 5.2.12.4 Target Customers /End-Users
    • 5.2.12.5 Key Personnel
    • 5.2.12.6 Analyst View
  • 5.2.13 TherapeuticsMD, Inc
    • 5.2.13.1 Company Overview
    • 5.2.13.2 Top Products / Product Portfolio
    • 5.2.13.3 Top Competitors
    • 5.2.13.4 Target Customers /End-Users
    • 5.2.13.5 Key Personnel
    • 5.2.13.6 Analyst View
  • 5.2.14 Other Companies

6 Research Methodology